Back |
home / stock / prfx / prfx message board
Subject | By | Source | When |
---|---|---|---|
I don't trade stocks, once I am out, | dinogreeves | investorshub | 07/22/2021 5:04:07 PM |
Playing for short term upper 5s during the | Yooo | investorshub | 07/22/2021 4:57:56 PM |
Me 2 | Yooo | investorshub | 07/22/2021 4:53:14 PM |
I doubled down on this dip again. | dinogreeves | investorshub | 07/22/2021 4:26:29 PM |
Sounds good. Lets see how it goes | Yooo | investorshub | 07/22/2021 4:17:20 PM |
I don't know it is hard to say | dinogreeves | investorshub | 07/22/2021 3:48:18 PM |
Dino, u think we have another NUR*? | Yooo | investorshub | 07/22/2021 3:39:36 PM |
Would love | Yooo | investorshub | 07/22/2021 3:29:35 PM |
Would move to see a close above $5 | Yooo | investorshub | 07/22/2021 3:29:22 PM |
Bought 4,30s | europtiger | investorshub | 07/22/2021 3:07:14 PM |
Awesome volume day! +102.87% | powerbattles | investorshub | 07/22/2021 1:42:31 PM |
Maybe a OR*PH move is pending here, who | dinogreeves | investorshub | 07/22/2021 1:08:59 PM |
News, Short Squeeze, Breakout and More Instantly...
PainReform Ltd. Company Name:
PRFX Stock Symbol:
NASDAQ Market:
Reaches 50% e nrollment in the s econd p art of its Phase 3 c linical t rial of PRF-110 in b unionectomy Remains on track to announce top-line data i n Q 3 202 4 TEL AVIV, Israel, May 15, 2024 (GLOBE N...
TEL AVIV, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (" PainReform " or the " Company "), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer o...
(NewsDirect) PainReform CEO Ilan Hadar joined Steve Darling from Proactive to discuss the company at the forefront of addressing the opioid crisis in the United States, is developing PRF-110, an innovative post-operative pain treatment designed as an alternative to traditional opioids. PR...